Biology of Blood and Marrow Transplantation
Volume 16, Issue 9 , Pages 1293-1301 , September 2010

Platelet-lysate-Expanded Mesenchymal Stromal Cells as a Salvage Therapy for Severe Resistant Graft-versus-Host Disease in a Pediatric Population

  • Giovanna Lucchini

      Affiliations

    • Clinica Pediatrica, Università Milano Bicocca, Ospedale San Gerardo, Monza, Italy
    • ,
  • Martino Introna

      Affiliations

    • USC Ematologia, Ospedali Riuniti di Bergamo, Bergamo, Italy
    • ,
  • Erica Dander

      Affiliations

    • Clinica Pediatrica, Università Milano Bicocca, Ospedale San Gerardo, Monza, Italy
    • ,
  • Attilio Rovelli

      Affiliations

    • Clinica Pediatrica, Università Milano Bicocca, Ospedale San Gerardo, Monza, Italy
    • ,
  • Adriana Balduzzi

      Affiliations

    • Clinica Pediatrica, Università Milano Bicocca, Ospedale San Gerardo, Monza, Italy
    • ,
  • Sonia Bonanomi

      Affiliations

    • Clinica Pediatrica, Università Milano Bicocca, Ospedale San Gerardo, Monza, Italy
    • ,
  • Agnese Salvadè

      Affiliations

    • Clinica Pediatrica, Università Milano Bicocca, Ospedale San Gerardo, Monza, Italy
    • ,
  • Chiara Capelli

      Affiliations

    • USC Ematologia, Ospedali Riuniti di Bergamo, Bergamo, Italy
    • ,
  • Daniela Belotti

      Affiliations

    • Clinica Pediatrica, Università Milano Bicocca, Ospedale San Gerardo, Monza, Italy
    • ,
  • Giuseppe Gaipa

      Affiliations

    • Clinica Pediatrica, Università Milano Bicocca, Ospedale San Gerardo, Monza, Italy
    • ,
  • Paolo Perseghin

      Affiliations

    • Centro Trasfusionale-UOS Aferesi, Ospedale San Gerardo, Monza, Italy
    • ,
  • Paola Vinci

      Affiliations

    • Clinica Pediatrica, Università Milano Bicocca, Ospedale San Gerardo, Monza, Italy
    • ,
  • Edoardo Lanino

      Affiliations

    • Dipartimento Ematologia-Oncologia Pediatrica, IRCCS Giannina Gaslini, Genova, Italy
    • ,
  • Patrizia Chiusolo

      Affiliations

    • Clinica Pediatrica, Istituto di Ematologia, Università Cattolica S. Cuore Roma, Italy
    • ,
  • Maria Grazia Orofino

      Affiliations

    • Clinica Pediatrica, Università di Cagliari, Cagliari, Italy
    • ,
  • Sarah Marktel

      Affiliations

    • Unità di Immunoematologia Pediatrica e Trapianto di Midollo Osseo, Istituto Scientifico Ospedale San Raffaele, Milano, Italy
    • ,
  • Jose Golay

      Affiliations

    • USC Ematologia, Ospedali Riuniti di Bergamo, Bergamo, Italy
    • ,
  • Alessandro Rambaldi

      Affiliations

    • USC Ematologia, Ospedali Riuniti di Bergamo, Bergamo, Italy
    • ,
  • Andrea Biondi

      Affiliations

    • Clinica Pediatrica, Università Milano Bicocca, Ospedale San Gerardo, Monza, Italy
    • Corresponding Author InformationCorrespondence and reprint requests: Ettore Biagi, MD, or Prof. Andrea Biondi, Laboratory of Cell Therapy “Stefano Verri,” Laboratorio M.Tettamanti, Avancorpo settore C, Clinica Pediatrica, Ospedale S.Gerardo dei Tintori, Via Donizetti 106, 20052, Monza (Mi), Italy.
    • ,
  • Giovanna D'Amico

      Affiliations

    • Clinica Pediatrica, Università Milano Bicocca, Ospedale San Gerardo, Monza, Italy
    • Ettore Biagi and Giovanna D'Amico are equal last authors.
    • ,
  • Ettore Biagi

      Affiliations

    • Clinica Pediatrica, Università Milano Bicocca, Ospedale San Gerardo, Monza, Italy
    • Corresponding Author InformationCorrespondence and reprint requests: Ettore Biagi, MD, or Prof. Andrea Biondi, Laboratory of Cell Therapy “Stefano Verri,” Laboratorio M.Tettamanti, Avancorpo settore C, Clinica Pediatrica, Ospedale S.Gerardo dei Tintori, Via Donizetti 106, 20052, Monza (Mi), Italy.
    • Ettore Biagi and Giovanna D'Amico are equal last authors.

Received 17 February 2010 ,Accepted 20 March 2010.

References 

  1. Ferrara JLM, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet. 2009;373:1550–1561
  2. Deeg HJ. How I treat refractory acute GVHD. Blood. 2007;109:4119–4126
  3. Siegel G, Schaefer R, Dazzi F. The immunosuppressive properties of mesenchymal stem cells. Transplantation. 2009;87:S45–S48
  4. Dazzi F, Marelli-Berg FM. Mesenchymal stem cells for graft-versus-host disease: close encounters with T cells. Eur J Immunol. 2008;38:1479–1482
  5. Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet. 2004;363:1439–1441
  6. Ringden O, Uzunel M, Rasmusson I, et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation. 2006;81:1390–1397
  7. Fang B, Song Y, Liao L, Zhang Y, Zhao RC. Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease. Transplant Proc. 2007;39:3358–3362
  8. Müller I, Kordowich S, Holzwarth C, et al. Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation. Blood Cells Mol Dis. 2008;40:25–32
  9. Baron F, Lechanteur C, Willems E, et al. Co-transplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following non-myeloablative conditioning. Biol Blood Marrow Transplant. 2010;Jan 25 [Epub ahead of print]
  10. Le Blanc K, Frassoni F, Ball L, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008;371:1579–1586
  11. von Bonin M, Stoelzel F, Goedecke A. Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing medium. Bone Marrow Transplant. 2009;43:245–251
  12. Kebriaei P, Isola L, Bahceci E. Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease. Biol Bone Marrow Transplant. 2009;15:804–811
  13. Kurtzberg J, Prasad V, Grimley MS, et al. Allogeneic human mesenchymal stem cell therapy (Prochymal) as a rescue agent for severe treatment resistant GvHD in pediatric population. Biol Blood Marrow Transplant. 2010;16:S169
  14. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18:295–304
  15. Capelli C, Salvade A, Pedrini O, et al. The washouts of discarded bone marrow collection bags and filters are a very abundant source of hMSCs. Cytotherapy. 2009;11:403–413
  16. Martin PJ, Uberti JP, Soiffer RJ, et al. Prochymal improves response rates in patients with steroid refractory acute graft versus host disease (SR-GVHD) involving the liver and gut: results of a randomized, placebo-controlled, multicenter phase III trial in GVHD. Biol Blood Marrow Transplant. 2010;16:S169–S170
  17. Siegel G, Schäfer R, Dazzi F. The immunosuppressive properties of mesenchymal stem cells. Transplantation. 2009;87(9 Suppl):S45–S49
  18. Polchert D, Sobinsky J, Douglas G, et al. IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. Eur J Immunol. 2008;38:1745–1755
  19. Ren G, Zhao X, Zhang L, et al. Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J Immunol. 2010;184:2321–2328
  20. Ren G, Su J, Zhang L, et al. Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells. 2009;27:1954–1962
  21. Welniak LA, Blazar BR, Murphy WJ. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol. 2007;25:139–170
  22. Nakamura H, Komatsu K, Ayaki M, et al. Serum levels of soluble IL-2 receptor, IL-12, IL-18, and IFN-gamma in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation. J Allergy Clin Immunol. 2000;106:S45–S50
  23. Dander E, Balduzzi A, Zappa G, et al. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation. Transplantation. 2009;15:1261–1272
  24. Karlsson H, Samarasinghe S, Ball LM, et al. Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses. Blood. 2008;112:532–541
  25. Capelli C, Domenghini M, Borleri G, et al. Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts. Bone Marrow Transplant. 2007;40:785–791
  26. Salvadè A, Della Mina P, Gaddi D, et al. Characterization of platelet lysate (PL)-cultured mesenchymal stromal cells (MSC) and their potential use in tissue-engineered osteogenic devices for the treatment of bone defects. Tissue Eng Part C Methods. 2009 May 26;[Epub ahead of print]

 Financial disclosure: See Acknowledgments on page 1301.

PII: S1083-8791(10)00135-7

doi: 10.1016/j.bbmt.2010.03.017

Biology of Blood and Marrow Transplantation
Volume 16, Issue 9 , Pages 1293-1301 , September 2010

Article Tools

* Image Usage & Resolution